Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR
Quality Evaluation of Dexpanthenol in Locally Marketed Dermatological Pharmaceutical and Cosmetic Creams and Monitoring their Stability during In-Use Shelf-Life
Prevalence of intestinal helminths infection in patients reporting to the microbiological laboratory at Tishreen University Hospital, Lattakia, Syria, during the years 2016-2017
Development and validation of a simple method for the determination of Atorvastatin calcium in pure and pharmaceutical formulations using spectrofluorimetry
Development and validation of a simple method for the determination of atorvastatin calcium in pure and pharmaceutical formulations using spectrofluorimetry
Evaluation of Technological and Microbiological Quality Aspects for Ophthalmic Tobramycin Preparations according to Editions of Different Pharmacopeias – A Comparative Study
The impact of foreign franchising on the mental image of the national medication and the repercussions of its loss under the crisis and the economic sanctions imposed
Novel Drug Selective Polystyrene Membrane for Simultaneous Potentiometric Determination of Ciprofloxacin and Tinidazole in Pure form and Pharmaceutical Formulations
Ionisable substances chromatography: A new approach for the determination of Ketoprofen, Etoricoxib, and Diclofenac sodium in pharmaceuticals using ion – pair HPLC
Development and validation of quality-control determination for ciprofloxacin in appearance of ciprofloxacin degradation products using ciprofloxacin selective sensor
Estimation of Nine Organic Volatile Impurities in Bulk Dapagliflozin propandiol hydrate and Dosage forms from different sources using a new developed HS-GC-FID method
Qualitative and Quantitative Determination of Dapagliflozin Propanediol Monohydrate and Its Related Substances and Degradation Products Using LC-MS and Preparative Chromatography Methods
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood–brain barrier in mice
P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example
Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier
Etude expérimentale de la variabilité des effets respiratoires de la buprénorphine : rôle de la P-glycoprotéine et de l’acquisition d’une tolérance aux opioïdes